BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Massive Bio Launches Free AI-Powered Portal to Simplify Cancer Clinical Trial Enrollment for Patients Worldwide

Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovati...

September 17, 2024 | News

Qritive Partners with Roche to Transform Cancer Diagnostics with AI-Powered Pathology Solutions

Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its collaboration with Roche, one of the largest ...

September 13, 2024 | News

Genea Biomedx Joins Basecare Medical to Drive Global Expansion of Assisted Reproductive Technology

Genea Biomedx, which was once part of Genea Fertility, joined the Basecare Medical group in 2023 with the aim of distributing Basecare's assisted reproduct...

September 13, 2024 | News

Jorge Sahlieh on Adapting Cardinal Health’s Products and Services to Tackle Healthcare's Pressing Financial and Workforce Challenges

In this exclusive interview with BioPharma APAC, Jorge Sahlieh, President of International Medical Products and Distribution at Cardinal Health, sh...

September 12, 2024 | Interview

MASSPHOTON and Sino Innovation Lab Launch World’s First Medical-Grade UVC LED Air Sterilizer

The experience of the COVID-19 pandemic has heightened global awareness of air quality and indoor environmental safety like never before. MASSPHOTON a...

September 12, 2024 | News

Hyundai Bioscience Announces XAFTY®: A Breakthrough Broad-Spectrum Antiviral for COVID-19, Mpox, and Dengue

Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease Prevention and Control Summit 2024" held in Philadel...

September 12, 2024 | News

GC Cell Partners with Indonesia’s Bifarma in Major Technology Transfer for Immuncell-LC Cancer Therapy

GC Cell, a leading innovator in cell therapy, has officially announced the execution of a landmark 'Technology Transfer and License Agreement' with PT Bifa...

September 11, 2024 | News

Australia Faces Urgent Call to Address Childhood Dementia Crisis in New 2024 Report

A groundbreaking new report, "State of Childhood Dementia in Australia 2024," released at Australia's Parliament House in Ca...

September 10, 2024 | Report

Antabio Completes Phase 1 Trial of MEM-ANT3310, Advancing Novel Antibacterial Treatment for Drug-Resistant Infections

Antabio, a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens, with a pa...

September 06, 2024 | News

Gender Disparities and Adherence Challenges Uncovered in Cardiovascular Disease Care: New Insights from Daiichi Sankyo

ifferences in cardiovascular disease (CVD) care have been identified, impacting clinical outcomes: There are gender differences in CVD care, spe...

September 03, 2024 | News

Thermo Fisher Scientific Expands Asian Operations with New Business Services Center in the Philippines

Thermo Fisher Scientific, the world leader in serving science, has announced the opening of a new Global Business Services Center (GBSC) in the Philippines...

September 03, 2024 | News

Sanyou Biopharmaceuticals Introduces Comprehensive Monkeypox Product Line Featuring Antigens, Monoclonal Antibodies, and Overexpression Cell Lines

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. announced the launch of a comprehensive product line targeting monkeypox, which includes antigens, monoclona...

September 02, 2024 | News

Guardant Health Japan Secures MHLW Approval for Guardant360® CDx as First Blood-Based Companion Diagnostic for EGFR Exon 20 NSCLC Mutations

Guardant Health Japan , a leading precision oncology company, announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan&nbs...

August 30, 2024 | News

UTime Signs NDA for Strategic Acquisition of Bowen Therapeutics Lab to Boost Global Vaccine Development

UTime Limited has officially announced the signing of a non-disclosure agreement (the "NDA") with Bowen Therapeutics Inc ("Bowen Therapeutics") for th...

August 29, 2024 | News

Stay Connected